Search for: "CIPLA LTD."
Results 1 - 20 of 47
Sorted by Relevance | Sort by Date
27 Apr 7:17 am
[Download] the Delhi High Court decision rejecting Roche appeal against the Delhi HC judgment dated March 19, 2008 declining their appeal for grant of an interim injunction to restrain
the Cipla from manufacturing, offering for sale, selling and exporting the drug Erlotinib. We will be bringing exclusive analysis on this
decision soon. Note: Our humble request to those having issue with our watermark, please refrain yourself from downloading the decision from our blog. This and other decisions ...
20 Apr, 2008 10:28 pm
... could be India's most path breaking patent decision till date. The key issue before the court was whether or not the patentee, Roche was entitled to a temporary injunction
restraining CIPLA from selling its version of Erlotinib, under the brand Erlocip. Echoing the findings in an old British case, American
Cyanamid Co vs Ethicon Ltd, the court held that a temporary injunction would issue in favour of Roche, only if it ...
6 Sep, 2007 12:33 pm
... Laboratories and H. Lundbeck A/S and enjoining Ivax Pharmaceuticals and Cipla Ltd. from infringing the '712 patent - but only as it
applies to escitalopram oxalate. See ... would have required undue experimentation. The district court concluded that Ivax and Cipla had failed
to prove by clear and convincing evidence that any of the asserted claims of ... inducement which we apply to 35 U.S.C. § 271(b), Cipla has
therefore actively induced the acts of Ivax that will constitute direct infringement upon ...
5 Sep, 2007 11:40 am
... During discovery, Forest learned that part of Ivax's ANDA submission included information provided by Mumbai-based Cipla, Ltd.,
Ivax's alleged EO drug supplier. ... , and sell the EO products described in the ANDA was undoubtedly a cooperative venture, and Cipla was to
manufacture and sell infringing EO products to Ivax for resale in the United States. ... inducement which we apply to 35 U.S.C. § 271(b), Cipla
has therefore actively induced the acts of Ivax that will constitute direct infringement upon ...
5 Sep, 2007 11:40 am
... During discovery, Forest learned that part of Ivax's ANDA submission included information provided by Mumbai-based Cipla, Ltd.,
Ivax's alleged EO drug supplier. ... , and sell the EO products described in the ANDA was undoubtedly a cooperative venture, and Cipla was to
manufacture and sell infringing EO products to Ivax for resale in the United States. ... inducement which we apply to 35 U.S.C. § 271(b), Cipla
has therefore actively induced the acts of Ivax that will constitute direct infringement upon ...
24 Jul, 2008 2:48 am
... week for the company to pay $13.5 million to settle the suit. Indian Drugmaker Openly Plans for Release of Copycats: Cipla Ltd,
India's second largest drug maker by sales, may launch copycat versions of 20 patented drugs of leading global drug makers, after securing similar-sounding trademarks for its copy
brands. Cipla "may launch these generic brands in the market as and when the opportunity arises", claimed a company executive, who didn't want
to ...
15 Apr 9:35 am
... opposition [download] for its anti-influenza drug Oseltamivir Phosphate marketed as Tamiflu. The Delhi Patent Office decided the pre-grant opposition in favor of Cipla Ltd. after it found that the applicant (Gilead) failed to provide any supportive evidence in the specification by means of comparative data or by
way of examples which would have supported the inventive merit of Oseltamivir. The Delhi Patent Office particularly relied on ...
11 Jul 1:15 pm
... Imatinib Meyslate application was filed in 1998 but it was not taken for examination till 2005 (mail-box application). Post 2005, the application was separately opposed by Cancer
Patients Aid Association, Natco Pharma Ltd., Cipla Ltd., Ranbaxy Ltd. and Hetero Drugs Ltd. and subsequently got
rejected by the Chennai Patent Office on January 25, 2006. Following refusal from the Chennai Patent Office, Novartis filed writ petitions before the Madras High ...
5 Sep, 2007 6:17 am
... the validity of a key patent on Forest Laboratories' blockbuster depression drug Lexapro and confirmed a lower court's decision to block sales of generic forms of the drug made by
Ivax (Teva Pharmaceutical Industries Ltd) and Cipla Ltd. The CAFC did alter D. Del.'s injunction so that it only applies to
escitalopram oxalate, the active ingredient in Lexapro. The CAFC decision gets into issues with enantiomers. A scientific publication by Smith had ...
25 Jan, 2008 1:00 am
... of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360), Ciprofloxacin - CIPLA
issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note ... Publishing Ltd concerning unauthorised
publication of photos football club members and Football Association Premier League Ltd v QC Leisure & Ors concerning the contractually prohibited providence of non-UK
decoder cards to ...
4 Apr, 2008 1:00 am
... Ranbaxy's subpoenas in US patent litigation: (IP Law360), Exjade (Deferasirox) - CIPLA set to launch generic Deferasirox in India; Novartis
has applied for an Indian patent on ... computer, without recitation of any specific means: Aristocrat Technologies Australia Pty Ltd v Int'l Game Technology: (Hal Wegner),
(Patent Prospector), (Patently-O ... more specific infringement contentions in patent case against EYS Metal Sanayi Ltd: (Washington State Patent Law Blog), Gibson Guitar -
Gibson Guitar files ...
16 Aug, 2008 2:43 am
... 't save patent term extension in the US: (The SPC Blog), Tarceva (Erlotinib) - India: Cipla counsel castigates Spicy IP sources for role in
blog post; 'public interest' ... reason why Australian patent law needs reform: Occupational and Medical Innovations Ltd v Retractable Technologies Inc: (IP Thinktank), Full
Federal Court finds ... three pending opposition proceedings in relation to applications for shades of purple: Cadbury UK Ltd v Registrar of Trade Marks: (Australian Trade Marks
Law Blog), IP ...
25 Nov 3:00 am
... (Class 46) India India: Legality of grey market goods in India: Roche v Cipla and Strix Limited v. Maharaja Appliances (Spicy IP) Delhi
High Court ... concerning alleged repudiatory breach of sponsorship agreement: Force India Formula One Team Ltd v Etihad Airways PJSC and Aldar Properties PJSC (IPKat) EWHC (Pat
... flashlight casing not de jure functional but lacking in distinctiveness: In re Brayco Products, Ltd (not precedential) (TTABlog) TTAB: rejects another fraud claim for
inadequate pleading: ...
1 Feb, 2008 12:00 am
... (Out-Law), (IPBiz), Tarceva (Erlotinib) - Roche patent infringement action against CIPLA before Delhi High Court: Many posts at: (Spicy IP)
and (Patent Circle) ... Generic Pharmaceuticals & IP), Tarceva (Erlotinib) - Roche patent infringement action against CIPLA before Delhi
High Court over Tarceva patent: (Update: the law on temporary ... not entitled to the word PURPLE for non-purple confectionary products in Cadbury Ltd v Effem Foods Ltd:
(IP Down Under) Norway Norwegian public broadcaster uses ...
5 Jul, 2008 11:05 am
... psoriasis cream upheld in patent proceedings: Leo Pharma & Anor v Sandoz Ltd: (IPKat), Effexor (Venlafaxine) - US: Wyeth files patent infringement suit against Biovail
... patent application for Nevirapine: (Spicy IP), (Spicy IP), Nexium (Esomeprazole) - India: Cipla obtains patent for new form of
Esomeprazole: (Patent Circle), Risperdal (Respiridone) - US: ... rules Zipher's patents invalid, cannot be amended: Zipher Ltd v Markem Systems Ltd & Anor: (IPKat),
UKIPO issues corporate plan: (IPKat) ...
28 Apr, 2008 11:00 am
... : Perindopril polymorph opposition dismissed: Les Laboratoires Servier v Apotex Pty Ltd: (IPRoo), Coversyl (Perindopril) - Canada: Court quashes 6 subpoenas, lets final one
... Book Blog), Tarceva (Erlotinib) - India: Ongoing patent dispute between Roche and CIPLA: (Spicy IP), (Interview with Roche's MD - Spicy
IP), Tarceva (Erlotinib) - ... (Class 46), High Court rules in favour of BBC in Dr Who copyright dispute: JHP Ltd v BBC Worldwide: (IPKat), Patent Court rules on costs in
Research in Motion UK ...
18 Jul, 2008 8:34 am
... suit: (SmartBrief), (SmartBrief), (IP Law360), Fosamax (Alendronate), Nexium (Esomaprazole) - India: Cipla beats s3(d) to obtain patents
for modified Nexium, and Fosamax: (International Law ... trade mark infringement proceedings after Customs seizure: Jamella Australia Pty Ltd v MacKinnon: (Australia & New
Zealand Intellectual Property Law) Belgium ... - another significant award: Louis Vuitton Malletier SA v 486353 BC Ltd: (Canadian Trademark Blog), Bill C-61 opposition mounting
in local ridings: ...
2 May, 2008 7:00 am
... India: (Spicy IP), Lexapro (Escitalopram) - Australia: The patentability of enantiomers: Alphapharm Pty Ltd v H Lundbeck A/S: (IPRoo), (IP Down Under), Lipitor (Atorvastatin
... Medicis: (Orange Book Blog), Tarceva (Erlotinib) - Delhi High Court restrains CIPLA from exporting generic Erlotinib to any country where
Roche has a patent for the drug, only ... IP), Court settles mischief of trade mark trafficking: Marc Enterprises Pvt Ltd v Five Star Electricals (India): (International Law
Office) Japan Japan ...
1 May 9:00 am
... : [duncanbucknell.com] Highlights this week included: Tarceva (Erlotinib) - India: Delhi High Court Appellate Bench holds in favour of Cipla against Roche in Tarceva patent litigation; Roche fined for 'material suppression' (Spicy IP) (PatLit) (Patent Circle) ( ... of demand (Korea IP Law
Blog) Tarceva (Erlotinib) - India: Delhi High Court Appellate Bench holds in favour of Cipla against Roche in Tarceva patent litigation; Roche
fined for 'material suppression' (Spicy IP) (PatLit) (Patent Circle) ( ...
25 Nov 12:00 pm
... ) Tavanic (Levofloxacin) - UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP) General Nil: The value of
patents in ... (Tangible IP) India: Legality of grey market goods in India: Roche v Cipla and Strix Limited v. Maharaja Appliances (Spicy IP)
India: Harmonising ... Tavanic (Levofloxacin) - UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP) Lipitor
(Atorvastatin) - EU/US: ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!